FDA Inspection 1010783 — Zhejiang Jingwei Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Jingwei Pharmaceutical Co., Ltd. on March 2, 2017 in Quzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Quzhou (China)